In-Vitro Diagnostics Packaging Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global in-vitro diagnostics packaging market was valued at USD 8.6 billion in 2024 and is estimated to grow at a CAGR of 5.1% from 2025 to 2034. Increasing needs for local production and packaging of diagnostic tests in developing economies have been a strong driver for the demand of in market.
Increasing interest in improving healthcare infrastructure of the country and reduced dependence on imports have led to a marked shift towards developing facilities within the country for manufacturing and packaging diagnostic tests. For instance, in December 2023, Codix Group, a subsidiary of Colexa Biosensor Ltd, received the approval of the World Health Organization to package the HIV Rapid Diagnostic Test in Nigeria. This achievement underscores the strengthening role of local manufacturing and packaging capacity in the in-vitro diagnostics (IVD) packaging market and thus reinforcing the accessibility to life-saving diagnostics in the regions of Africa.
| Report Attribute | Details |
|---|---|
| Base Year: | 2024 |
| In-Vitro Diagnostics Packaging Market Size in 2024: | USD 8.6 Billion |
| Forecast Period: | 2025 - 2034 |
| Forecast Period 2023 - 2032 CAGR: | 5.1 |
| 2023 Value Projection: | USD 13.9 Billion |
| Historical Data for: | 2021 - 2024 |
| No of Pages: | 220 |
| Tables, Charts & Figures: | 560 |
| Segments Covered: | Product, Application, End User |
| Growth Drivers: |
|
| Pitfalls Challenges: |
|
The in vitro diagnostics packaging industry is currently witnessing an increasing focus towards environmental sustainability and eco-friendliness, which is one of the key trends. With the healthcare sector moving towards adopting greener practices, there is an increasing tendency for manufacturers to seek more biodegradable and recyclable options. Also, there has been a noteworthy contribution of integrating smart capabilities into packaging in diagnosing products; for instance, RFID tags and sensors enhance the visibility of the supply chain and also the compliance with right conditions. These innovations are crucial for achieving both environmental objectives and the need for improved efficiency in the IVD industry.
The influx in popularity and demand for point-of-care diagnostics as well as personalized medications have opened up new avenues for the IVD packaging industry. This demand facilitates the trend of compact, cost-effective, and most importantly smaller packaging, which in return allows manufacturers to meet sustainability goals without compromising practicality. IVD diagnostics packaging materials have been on the rise due to the growing consumer base's demands.
Based on product, the in-vitro diagnostics packaging market is divided into bottles and vials, tubes, petri dishes, closures, and others. The bottles and vials segment is expected to reach a value of over USD 4 billion by 2034.
Based on end user, the in-vitro diagnostics packaging market is divided into hospitals, laboratories, academic institutes, and others. The academic institutes segment is the fastest growing segment with a CAGR of over 7% between 2025 and 2034.
North America in-vitro diagnostics packaging market held the share of over 35% in 2024. The US is witnessing a remarkable increase in the in-vitro diagnostics (IVD) packaging market owing to several prerequisites. The nation is regarded as the hub of medical technology developments with multifaceted focus on diagnostics and healthcare technology through research and development. The inclusivity of point-of-care testing, personalized medicine, and an aging population drives the evolution of specialized IVD packaging solutions across the US healthcare system.
China's healthcare sector is growing at a rapid pace, which is expected to promote the adoption of advanced diagnostic solutions, resulting in significant expansion of the in-vitro diagnostics packaging industry in the country. Due to the rising prevalence of chronic diseases combined with an aging population, there is a greater need for medical equipment and tools that are packaged safely and effectively. Moreover, the growth of China's medical research and diagnostic technologies is moving the market toward more effective IVD packaging solutions, which ensure the safety and effectiveness of diagnostic tests in the market?.
In India, the market is witnessing an upward trend owing to the need for affordable healthcare facilities in still developing and underdeveloped regions of the country. There is a persistent search for cost-effective diagnostic packaging that protects the test, advancing the segment's growth?.
The in-vitro diagnostics packaging market in South Korea has been experiencing expansion backed by high investments in biotechnology and innovation in the healthcare sector. As the country strides towards advancing technologies in diagnosis, the requirement for qualitative packaging is also on the rise.
Japan's rising interest in self-medication along with the growing elderly population is resulting in the growth of the country’s in-vitro diagnostics packaging industry. There is increasing demand in Japan for high-security, dependable, and eco-friendly packaging as a result of the expansion of the local healthcare industry and the growing demand for modern diagnostic equipment.
Key components that drive competition in the in vitro diagnostics (IVD) packaging market are price and cost-sensitivity of emerging markets. Companies have begun to treat each new concept separately to highlight the need to include new ideas that involve using alternative materials or distinguishing features for the package such as smart technology, including RFID tags for tracking. Expansion of distribution channels also broadens the competitive space, with an emphasis on reaching target customers with efficient supply chain management to deliver the packaging solutions on time to the manufacturers of the diagnostic products?.
Major players operating in the in-vitro diagnostics packaging industry are:
Market, By Product
Market, By Application
Market, By End User
The above information is provided for the following regions and countries:
The North America in-vitro diagnostics packaging market held over 35% of the global share in 2024, with growth driven by the U.S.'s leadership in medical technology innovation and increasing demand for advanced diagnostic solutions.
Key players in the market include Abdos Labtech, Academy Medical Instruments, AdvaCare Pharma, Amcor, Amrit Scientific, Ajosha Bio Teknik, Aptargroup, Corning, Focus Technology, Fusion Biotech, Globe Scientific, Greiner Holding, Kindly Group, and Labtech Disposables.
The global in-vitro diagnostics packaging industry was valued at USD 8.6 billion in 2024 and is projected to grow at a 5.1% CAGR from 2025 to 2034, driven by increasing demand for local manufacturing and packaging of diagnostic tests in emerging markets.
The bottles and vials segment is expected to exceed USD 4 billion by 2034, as these containers provide superior protection against contamination, moisture, and light, ensuring the stability and accuracy of IVD products.